 |
BD43495 |
Cinchonan-9-ol, 6′-methoxy-, (8α,9R)-, compd. with arsenic acid (H3AsO4) (3:2), pentahydrate |
6151-54-8 |
C20H29AsN2O7 |
484.3751 |
VIEW DETAILS > |
 |
BD43248 |
Carbonic acid, compd. with 2-heptanamine (1:1) |
71411-82-0 |
C8H19NO3 |
177.2414 |
VIEW DETAILS > |
 |
BD43653 |
Carbonic acid, compd. with 4-methyl-1,3-cyclohexanediamine (1:1) |
93805-50-6 |
C8H18N2O3 |
190.2401 |
VIEW DETAILS > |
 |
BD44115 |
Cinchonan-6′,9-diol, (8α,9R)-, compd. with (8α,9R)-6′-methoxycinchonan-9-ol (1:1) |
6574-32-9 |
C39H46N4O4 |
634.8069 |
VIEW DETAILS > |
 |
BD59781 |
Cholan-24-oic acid, 3,7-dihydroxy-, iron(2+) salt (1:?), (3α,5β,7α)- |
165048-41-9 |
C24H40FeO4 |
448.417 |
VIEW DETAILS > |
 |
AF09841 |
Combivir |
165456-81-5 |
C18H24N8O7S |
496.4976 |
VIEW DETAILS > |
 |
AH75605 |
calcium 4-[(4-ethoxy-2-sulphonatophenyl)azo]-3-hydroxy-2-naphthoate |
84696-58-2 |
C19H14CaN2O7S |
454.4667 |
VIEW DETAILS > |
 |
BE26514 |
Chromate(1-), bis[3-[2-[1-(3-chlorophenyl)-4,5-dihydro-3-methyl-5-(oxo-κO)-1H-pyrazol-4-yl]diazenyl-κN1]-4-(hydroxy-κO)benzenesulfonamidato(2-)]-, hydrogen, compd. with 1,6-hexanediamine (1:1:1) |
71839-79-7 |
C38H40Cl2CrN12O8S2 |
980.8398 |
VIEW DETAILS > |
 |
BD46928 |
Cortisol, 21-(hydrogen succinate), compd. with dihydrostreptomycin (3:1) |
34501-14-9 |
C46H75N7O20 |
1046.1226 |
VIEW DETAILS > |
 |
BD46976 |
Cuprate(4-), [μ-[[3,3′-[[3,3′-di(hydroxy-κO)[1,1′-biphenyl]-4,4′-diyl]bis(2,1-diazenediyl-κN1)]bis[5-amino-4-(hydroxy-κO)-2,7-naphthalenedisulfonato]](8-)]]di-, hydrogen, compd. with morpholine (1:4:4) |
65121-91-7 |
C36H25Cu2N7O17S4 |
1083.9803 |
VIEW DETAILS > |